The first trial in more than 3,000 Actos lawsuits filed in the U.S. is currently being heard in a Los Angeles court. Lawyers at Carey Danis & Lowe reported last week that the first Actos trial began with revelatory information about Takeda Pharmaceutical’s misleading marketing strategy.
Apparently, the Japanese pharmaceutical company was knowledgeable of the health problems associated with Actos ingestion, but decided to hide that information in order to market the diabetes drug.
Since Carey Danis & Lowe’s update last week, the trial involving plaintiff, Jack Cooper, has convened again for opening arguments from both sides, and expert testimony from a pharmacologist.
Jack Cooper filed a lawsuit against the manufacturer of Actos, Takeda Pharmaceuticals, citing that the pharmaceutical company failed to warn Actos users and healthcare providers about the risks of using the diabetes medicine, especially about the link between Actos and bladder cancer.
A Bloomberg article about the trial states that Cooper developed bladder cancer in 2011. Though Cooper alleges his bladder cancer is a result of ingesting Actos for four years, a lawyer representing Takeda pointed to the plaintiff’s lifestyle to explain his current health condition.
On March 4, Howard Greenberg, a clinical pharamacologist, delivered expert testimony about Takeda’s priorities regarding Actos. Greenberg noted that upon analyzing internal Takeda emails, it became clear that profits from Actos took precedence over consumer safety.
The content of these emails reveals that Takeda executives were concerned about the drug’s viability on the market if pharmaceutical regulators, like the U.S. Food and Drug Administration, ordered that the Actos drug label include information about bladder cancer. These emails go on to express that a bladder cancer warning would be a “worst-case scenario”, according to Bloomberg.
Cooper’s case is being heard in a California Superior Court in Los Angeles, and has been filed as Cooper v. Takeda Pharmaceuticals America Inc.
The worst-case scenario being poor drug sales resulting from a bladder cancer warning illustrates Takeda’s egregious disregard for consumer safety. Lawyers at Carey Danis & Lowe work diligently for our clients to hold pharmaceutical companies accountable for the harm their products cause consumers.
If you or someone you love has been injured by the use of Actos, and as a result, has developed bladder cancer, you and your loved one may be eligible to receive compensation.
For a free legal evaluation and for more information about filing an Actos bladder cancer lawsuit, contact an experienced trial lawyer at Carey Danis & Lowe today by calling 800.721.2519 or by submitting a legal claim form.